Zobrazeno 1 - 6
of 6
pro vyhledávání: '"María, Hu"'
Autor:
Carolina Ayelen Isnardi, Dafne Capelusnik, Emilce Edith Schneeberger, María de los Ángeles Correa, Romina Lim, María Hu, María Janina Tapia, Eduardo Kerzberg, Eliana Blanco, Federico Luján Benavídez, Luciana González Lucero, Ana Lucía Barbaglia, Marcela Bazzarelli, Hernán Maldonado Ficco, Silvana Pérez, Claudia Hartvig, Mariana Salcedo, Gustavo Citera
Publikováno v:
Revista Argentina de Reumatología, Vol 30, Iss 1 (2019)
Recientemente, validamos el cuestionario Quality of Life-Rheumatoid Arthritis Scale (QOL-RA) y detectamos la presencia de algunas limitaciones. Por esta razón, con la autorización de la autora, cambiamos dos preguntas y desarrollamos una nueva vers
Externí odkaz:
https://doaj.org/article/e3ab8825b0764d8b87b6912d51af10f7
Autor:
A. L. Barbaglia, María de los Ángeles Correa, María Janina Tapia, Eliana Blanco, Eduardo Kerzberg, Emilce Edith Schneeberger, Federico Luján Benavidez, Hernán Maldonado Ficco, Claudia Hartvig, Mariana Salcedo, Marcela Bazzarelli, Gustavo Citera, Dafne Capelusnik, Luciana Gonzales Lucero, Romina Lim, Silvana Pérez, C. A. Isnardi, María Hu
Publikováno v:
Clinical Rheumatology. 39:3309-3315
To validate the Quality of Life-Rheumatoid Arthritis Scale II (QOL-RA II) in an Argentinean cohort of patients with rheumatoid arthritis (RA). Patients ≥ 18 years old, with a diagnosis of RA according to ACR-EULAR 2010 criteria, were included in a
Autor:
Carolina Ayelen Isnardi, Dafne Capelusnik, Emilce Edith Schneeberger, María de los Ángeles Correa, Romina Lim, María Hu, María Janina Tapia, Eduardo Kerzberg, Eliana Blanco, Federico Luján Benavídez, Luciana González Lucero, Ana Lucía Barbaglia, Marcela Bazzarelli, Hernán Maldonado Ficco, Silvana Pérez, Claudia Hartvig, Mariana Salcedo, Gustavo Citera
Publikováno v:
Revista Argentina de Reumatología. :16-21
We have recently validated the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA). We have found some limitations, that is why, with the author’s permission, we have changed two questions and developed a new Spanish version, QOL-RA II. Objective:
Autor:
Carolina Ayelen, Isnardi, Emilce Edith, Schneeberger, Dafne, Capelusnik, María, de Los Ángeles Correa, Romina, Lim, María, Hu, María Janina, Tapia, Eduardo, Kerzberg, Eliana, Blanco, Federico Luján, Benavidez, Luciana, Gonzales Lucero, Ana Lucía, Barbaglia, Marcela, Bazzarelli, Hernán Maldonado, Ficco, Silvana, Pérez, Claudia, Hartvig, Mariana, Salcedo, Gustavo, Citera
Publikováno v:
Clinical rheumatology. 39(11)
To validate the Quality of Life-Rheumatoid Arthritis Scale II (QOL-RA II) in an Argentinean cohort of patients with rheumatoid arthritis (RA). Patients ≥ 18 years old, with a diagnosis of RA according to ACR-EULAR 2010 criteria, were included in a
Autor:
Florencia Mollerach, Maximiliano Machado Escobar, Marina Scolnik, Belen Maria Virasoro, Maria Jose Lopez Perez, Mercedes Croce, Rosa Serrano Morales, Diana Dubinsky, Adrián Estevez, Paula Alba, Fabiola Natalia Camargo Serrudo, Cruz Lascano, María Constanza Danielsen, María de la Paz Leon, Cintia Otaduy, Laura Onetti, Cecilia Alvarez, Verónica Bellomio, Daniela Flores Rengifo, Mayra Etcheverry, V. Savio, María Hu, Marina Werner, Fernanda Guzzanti, Eduardo Kerzberg, C. Gobbi, C. Maldini, Emma E. Civit, Cecilia Pisoni, Ana M. Bertoli, Alejandra M. Babini, Verónica Saurit
Publikováno v:
Abstracts.
Background Neonatal lupus (NL) is a disease in children of mothers who have specific anti-Ro/La IgG autoantibodies by passive transplacental transfer. LN is characterized by skin and cardiac involvement, as well as cytopenias, hepatic or neurological
Autor:
S. Roverano, M. E. Crespo Espindola, A. L. Barbaglia, C. Goizueta, M. Cosatti, Dafne Capelusnik, L. Gonzalez Lucero, R. Calvo, H. R. Sueldo, M. L. Leguizamón, R. Águila Maldonado, L. M. Galindo, Y. Soria Curi, M. C. Bertolaccini, G. V. Espasa, Cecilia Pisoni, R. Rojas Tessel, S. M. Mazza, E. Picco, Verónica Bellomio, Mirta Santana, Mónica García, María Hu, L. Alascio, M. Micelli, P. Avila
Publikováno v:
Annals of the Rheumatic Diseases. 79:908.2-908
Background:The mortality rate in patients with systemic lupus erythematosus (SLE) is 2–3 times higher than in the general population. However, survival in these patients has improved significantly and is currently 95% at 5 years according to differ